Tenet's Q2 Crushes Estimates, Sends Stock Soaring
A much larger-than-expected quarter and an upgraded outlook point to stronger cash flow that could lift Tenet’s valuation but leave questions about persistence.
Overview
- Tenet reported a blockbuster second quarter with $826 million in net income and a 26.7% operating margin driven by $5.6 billion in operating revenue.
- The company raised full-year guidance to $21.9–$22.5 billion in net operating revenue, $2.87–$3.02 billion in net income, and $20.30–$21.69 in adjusted EPS.
- Results were helped by hospital volume gains and ambulatory same‑facility growth, and included a one‑time $413 million revenue recognition tied to the early end of Conifer’s contract with CommonSpirit Health.
- Investors re‑rated the shares after the report, sending the stock roughly 23% higher and prompting Barclays to lift its price target to $271 and keep an Overweight rating.
- Analysts say the results boost Tenet’s cash flow and buyback capacity but warn that some margin drivers may not repeat because of the one‑time contract payment and changing payer mix for uninsured and exchange patients.